Complete Stereochemistry of Neamphamide A
istry groups. As a result, syntheses of structural subunits
such as 3,4-dimethylglutamine (3,4-diMeGln),5 4-amido-
7-guanidino-2,3-dihydroxyheptanoic acid (3, Agdha),6 and
3-hydroxy-2,4,6-trimethylheptanoic acid (4, Htmha)7 have
been described. These efforts provided essential building
blocks for use in total synthesis of the parent peptides,
and they also helped to unambiguously define the abso-
lute stereochemistry of several key stereogenic centers.
However, synthetic efforts to prepare the intact natural
products have been hampered by unresolved questions
concerning the stereochemistry of the â-methoxytyrosine
(5, âOMeTyr) residues, which occur throughout this
family of peptides. While stereoselective syntheses of all
four diastereomers of 5 have been reported,8 the absolute
stereochemistry of this residue in the natural peptides
was never established. Decomposition of 5 during acid
hydrolysis of the parent peptide prevented the successful
application of standard techniques such as Marfey’s
analysis.9 In the original report of neamphamide A (1),
the chirality of the Agdha, Htmha, and âOMeTyr resi-
dues was left undefined. Described herein is the first
complete stereochemical assignment of neamphamide A
(1) and a general method for determining the absolute
stereochemistry of âOMeTyr (5) residues in other pep-
tides. This technique was also used to unambiguously
define the stereochemistry of the same residue in pap-
uamide B (2), and the results of these analyses should
help focus the synthetic efforts underway to prepare the
parent peptides.
Results and Discussion
Our prior studies had established the absolute stere-
ochemistry of nine amino acid residues of neamphamide
A (1) as D-Arg, L-Leu, D- and L-Asn, L-NMeGln, L-
homoproline, D-allo-Thr (two residues), and (3S,4R)-3,4-
diMe-L-Gln. In addition, C4 of the Agdha (3) moiety was
assigned a S-configuration by chemical degradation
involving diol-cleavage, oxidative work up, and acid
hydrolysis, followed by Marfey’s analysis of the resulting
arginine subunit.1 In the current study, a synthetic
standard of 3 with defined stereochemistry was available
for comparative purposes,6 but direct application of
Marfey’s method to the peptide hydrolysate to determine
the stereochemistry at C2 and C3 proved unsuitable. The
L-FDAA derivative of 3 had poor retention on reversed-
phase chromatography packings and unacceptable peak
broadening in the LC-MS analysis. Accordingly, the
γ-amino acid 3 was isolated from the hydrolysate of 1
and converted into cyclic derivatives appropriate for
NMR-based configurational analysis at C2, C3, and C4.
Compound 1 was hydrolyzed in 6 N HCl (107 °C, 18.5
h), defatted with EtOAc, and the resulting aqueous
hydrolysate was purified by anion- and then cation-
exchange chromatography to give a mixture of 3 and Arg.
While dissolved in CD3OD for NMR studies, compound
3 was gradually converted to the trideuteriomethyl ester
derivative 6. This transformation was evidenced from 1H
resonances at δ 4.10 (H3 of 3) and 4.37 (H2 of 3), which
diminished in intensity, while resonances at δ 3.97 (H3
of 6) and 4.35 (H4 of 6) emerged and grew with time
(Supporting Information). Positive ion ESI-MS data
obtained before and after the NMR experiments showed
the appearance of a dominant ion peak at m/z 25210 and
(4) Trevisi, L.; Bova, S.; Cargnelli, G.; Danieli-Betto, D.; Floreani,
M.; Germinario, E.; D’Auria, M. V.; Luciani, S. Biochem. Biophys. Res.
Commun. 2000, 279, 219-222. (b) Trevisi, L.; Cargnelli, G.; Ceolotto,
G.; Papparella, I.; Semplicini, A.; Zampella, A.; D’Auria, M. V.; Luciani,
S. Biochem. Pharmacol. 2004, 68, 1331-1338.
(5) (a) Liang, B.; Carroll, P. J.; Joullie, M. M. Org. Lett. 2000, 2,
4157-4160. (b) Okamoto, N.; Hara, O.; Makino, K.; Hamada, Y.
Tetrahedron: Asymmetry 2001, 12, 1353-1358. (c) Acevedo, C. M.;
Kogut, E. F.; Lipton, M. A. Tetrahedron 2001, 57, 6353-6359.
(6) Thoen, J. C.; Morales-Ramos, AÄ . I.; Lipton, M. A. Org. Lett. 2002,
4, 4455-4458.
(7) (a) Guerlavais, V.; Carroll, P. J.; Joullie´, M. M. Tetrahedron:
Asymmetry 2002, 13, 675-680. (b) Zampella, A.; Sorgente, M.; D’Auria,
M. V. Tetrahedron: Asymmetry 2002, 13, 681-685. (c) Zampella, A.;
D’Auria, M. V. Tetrahedron: Asymmetry 2002, 13, 1237-1239. (d)
Turk, J. A.; Visbal, G. S.; Lipton, M. A. J. Org. Chem. 2003, 68, 7841-
7844.
(8) (a) Okamoto, N.; Hara, O.; Makino, K.; Hamada, Y. J. Org. Chem.
2002, 67, 9210-9215. (b) Hansen, D. B.; Wan, X.; Carroll, P. J.; Joullie´,
M. M. J. Org. Chem. 2005, 70, 3120-3126.
(9) Marphy, P. Carlsberg Res. Commun. 1984, 49, 591-596.
J. Org. Chem, Vol. 70, No. 17, 2005 6843